Contact your GP or diabetes specialist nurse to discuss adjusting the doses of any other diabetes medications you are taking, as dose reductions may be necessary to prevent recurrent hypoglycaemia
We answer these questions before anything gets prescribed: We build a strategy around the individual, the goal, the full clinical picture, and whether the approach is effective
67 Insufficient literature was identified to constitute an evidence base for diagnosis of IC/BPS in clinical practice
In order to evaluate substantial clinical improvement over currently available treatments to meet the transitional pass-through payment criterion at 419.66(c)(2), we stated that we consider supporting evidence, preferably published peer-reviewed clinical trials, that demonstrates improved clinical outcomes, such as reduction in mortality, complications, subsequent interventions, future hospitalizations, recovery time, pain, or a more rapid beneficial resolution of the disease process comparing the nominated device to the standard of care (88 FR 81733)
Plasma half-life is about 159-195 hours, or roughly 6.6-8.1 days
